U

Umecrine Cognition AB

6 employees

Umecrine Cognition has develops drugs against central nervous system neurological disorders, CNS caused by endogenous CNS active steroids.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Pharmaceutical

Date founded

2006

Funding rounds raised

Total raised

$2.5M

from 4 investors over 4 rounds

U

Umecrine Cognition AB raised $2.5M on October 4, 2017

Investors: Norrlandsfonden, Partnerinvest Norr and Karolinska Development

U

Umecrine Cognition AB raised undisclosed on January 1, 2016

Investors: Almi Invest

FAQ